STOCK TITAN

SRAX SEC Filings

SRAX OTC

SRAX Inc. (SRAX) is described in public communications as a financial technology company that unlocks data and insights for publicly traded companies through its Sequire investor intelligence and communications platform. While no recent SEC filings are listed here, regulatory documents such as annual reports, quarterly reports, and current reports have historically provided detailed information about SRAX’s business, risks, capital structure, and significant corporate events.

Company announcements indicate that SRAX has experienced changes in its reporting and listing status, including a delisting from the Nasdaq market and subsequent trading on the OTC Expert Market. In a shareholder letter, SRAX discussed efforts to get its filings back in order, complete audits, and address reporting requirements. These topics are typically reflected in SEC filings, including audited financial statements and related disclosures.

SRAX has also announced a definitive merger agreement with DNA Holdings Venture Inc., under which DNA shareholders are expected to become the majority owners of SRAX’s outstanding common stock upon closing, subject to stockholder approvals and other conditions. The company has stated that additional information about this proposed transaction, including a copy of the business combination agreement, would be provided in a Current Report on Form 8-K to be filed with the SEC. Such filings are central sources for understanding the terms, contingencies, and potential effects of the merger on existing shareholders.

For investors analyzing SRAX, SEC filings historically have been the primary place to review detailed financial results, management’s discussion and analysis, risk factors, and information about equity, debt, and other obligations. Filings related to governance changes, such as board composition or the creation of advisory structures, as well as documents describing significant asset sales or partnerships, also help provide a fuller picture of the company’s regulatory and corporate history.

On this page, SRAX’s SEC filings can be reviewed alongside AI-powered tools that summarize lengthy documents and highlight key sections. These tools are designed to help readers quickly identify important topics in filings such as annual and quarterly reports or current reports about major transactions, while still allowing access to the full original documents for detailed analysis.

15-12G
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
other

FAQ

How many SRAX (SRAX) SEC filings are available on StockTitan?

StockTitan tracks 1 SEC filings for SRAX (SRAX). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for SRAX (SRAX)?

The most recent SEC filing for SRAX (SRAX) was filed on November 12, 2026.